Neck pain is the fourth leading cause of disability, with an annual prevalence rate exceeding
30%. Most episodes of acute neck pain will resolve with or without treatment, but nearly 50 …

Temporomandibular disorders (TMD) are a heterogeneous group of musculoskeletal and
neuromuscular conditions involving the temporomandibular joint complex, and surrounding …

Functional somatic syndromes (FSS), like irritable bowel syndrome or fibromyalgia and other
symptoms reflecting bodily distress, are common in practically all areas of medicine …

Since its introduction as a treatment for strabismus, botulinum toxin (BoNT) has had a
phenomenal journey and is now recommended as first-line treatment for focal dystonia …

Myofascial pain syndrome (MPS) is a painful condition of myofascial trigger points (MTrPs)
in the skeletal muscle. 1 It can occur alone or in combination with other pain generators …

Myofascial pain syndrome (MPS) is defined as pain that originates from myofascial trigger
points in skeletal muscle. It is prevalent in regional musculoskeletal pain syndromes, either …

Background Approximately 10% of the general population and around one third of adult
patients in clinical populations suffer from functional somatic symptoms. These take many …

Chronic pelvic pain is a common, burdensome, and costly condition that disproportionately
affects women. Diagnosis and initial management of chronic pelvic pain in women are within …

Myofascial pain syndrome (MPS) has been defined as a regional pain syndrome
characterized by muscle pain caused by myofascial trigger points (MTrPs) clinically. MTrP is …

Botulinum neurotoxin type A (BoNT/A) is one of the most potent toxins known and a potential
biological threat. At the same time, it is among the most widely used therapeutic proteins …